MicroRNA‐379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF‐4
Jin‐Long Wei, Liang Zhang, Zhi‐Ming Zhao and 3 more
Kaohsiung Journal of Medical Sciences · 2019
doi:10.1002/kjm2.12109 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract The expression pattern, functions, and detailed regulatory mechanisms of miR‐379 in laryngeal carcinoma remain unknown. In the present study, we aimed to uncover novel potential miR‐379 targets and shed light on its roles in laryngeal carcinoma. The expression level of miR‐379 was measured based on the data obtained from the TCGA database and the cell lines. After miR‐379 mimic transfection, cell proliferation, invasion and migration assay, and wound‐healing assay in HEp‐2 cell line were implemented to evaluate the effects of miR‐379 on laryngeal carcinoma in vitro. The target genes for miR‐379 in silico were predicted and validated using luciferase reporter assay. The miR‐379 expression level was reduced in laryngeal carcinoma tissues and cell lines. Moreover, miR‐379 overexpression inhibited the cell proliferation, migration, and invasion of laryngeal carcinoma cells. TCF‐4 was detected as a direct target of miR‐379 in laryngeal carcinoma. Furthermore, restored TCF‐4 expression rescued the inhibitory roles of miR‐379 overexpression on cell proliferation, migration, and invasion.Our study for the first time demonstrated that miR‐379/TCF‐4 might involve in the progression of laryngeal carcinoma, and miR‐379 appears to serve as a novel tumor suppressor in laryngeal carcinoma.
Abstract licence: CC BY-NC-ND
References32
32 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.